Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/113759
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Fc-γ receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer |
Other Titles: | Fc-gamma receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer |
Author: | Liu, G. Tu, D. Lewis, M. Cheng, D. Sullivan, L. Chen, Z. Morgen, E. Simes, J. Price, T. Tebbutt, N. Shapiro, J. Jeffery, G. Mellor, J. Mikeska, T. Virk, S. Shepherd, L. Jonker, D. O'Callaghan, C. Zalcberg, J. Karapetis, C. et al. |
Citation: | Clinical Cancer Research, 2016; 22(10):2435-2444 |
Publisher: | American Association for Cancer Research |
Issue Date: | 2016 |
ISSN: | 1078-0432 1557-3265 |
Statement of Responsibility: | Geoffrey Liu, Dongsheng Tu, Marcia Lewis, Dangxiao Cheng, Leslie A. Sullivan, Zhuo Chen, Eric Morgen, John Simes, Timothy J. Price, Niall C. Tebbutt, Jeremy D. Shapiro, G. Mark Jeffery, J. Daniel Mellor, Thomas Mikeska, Shakeel Virk, Lois E. Shepherd, Derek J. Jonker, Christopher J. O'Callaghan, John R. Zalcberg, Christos S. Karapetis, and Alexander Dobrovic |
Abstract: | Abstract not available |
Keywords: | Cetuximab therapy |
Rights: | ©2016 American Association for Cancer Research. |
DOI: | 10.1158/1078-0432.CCR-15-0414 |
Appears in Collections: | Aurora harvest 3 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.